Management
CEO, CO-FOUNDER & BOARD MEMBER
Previously a CEO of a start up company from idea to application and from concept to a successful publicly traded company. Extensive management and financial experience. Financially lead a variety of international and public companies. Led private equity raising for public companies. Strong Involvement in M&A transactions.
CTO
Dr. Nedvetzki has over 20 years’ experience in the biomedical R&D industry, primarily focused on the development of drugs and medical devices. Dr. Nedvetzki previously served as a R&D Manager and Senior Pre-Clinical Manager at Polypid Ltd., where he headed development of drug and drug/device combination products, overseeing every aspect of drug discovery/development, through preclinical and clinical planning and management. Before that served as Drug Development Manager at BioLineRx Ltd. Dr. Nedvetzki earned his Ph.D. in immunology from the Hebrew University of Jerusalem and did his post-doctoral work at Imperial College in the UK.